Medicine & Healthcare Pharmaceutical sciences
News
26 Feb 2026
Glutamine transporter inhibition has been found to suppress cell growth
26 Jan 2026
An international research team led by The University of Osaka has demonstrated that two-faced Janus nanoparticles can restore the effectiveness of antibiotics against drug-resistant bacteria. These particles disrupt the protective outer membrane of Gram-negative bacteria, which normally blocks antibiotics. This allows conventional drugs to regain access and kill the once-resistant microbes. This synergistic strategy restores the effectiveness of existing antibiotics, offering a new line of defense against the growing threat of superbugs and extending the utility of our current medical arsenal.
27 Oct 2025
A new study suggests that the same henna pigments that change your skin or hair that distinctive orange-red color could be used for another purpose: treating liver disease.
15 Jul 2025
Protein aggregation inhibitor shows lower levels of cell death and paralysis in mice with acute strokes
11 Apr 2025
New research in model mice suggests low-dose opioids may help improve social interactions in people with autism spectrum disorder.
28 Mar 2025
Researchers develop innovative phospholipids that improve the functional delivery of mRNA via lipid nanoparticles, paving the way for advanced therapeutic applications.
24 Jan 2025
At Duke-NUS Medical School scientists are pioneering breakthroughs in precision medicine and regenerative therapies, targeting everything from muscle loss to dramatically extending our years of health.
18 Nov 2024
SGLT2 inhibitor canagliflozin helps oxygenate kidneys while causing glucose removal through urine
22 Aug 2024
A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.
12 Jul 2024
A method to screen a wide variety of drug candidates without laborious purification steps could advance the fight against drug-resistant bacteria.
21 Feb 2024
Regenerative therapy to treat heart failure is more effective when the mitochondria of the regenerative cells are activated prior to treatment.
09 Nov 2023
New shrimp species in ancient hot spring, Super sprouts, How "warm-ups" work, New antiviral candidate, Solving voltage decay and from our blog: A sustainable future shines in TIE 2023. Read all in the latest Editor's Choice.
20 Oct 2023
A broad-spectrum antiviral drug candidate, 2-thiouridine, that targets positive-strand RNA viruses has been identified and characterized.
11 Jul 2023
The entire biosynthetic pathway of actinopyridazone has been unveiled, revealing that an unprecedented carrier protein-mediated ring-forming step is key to its synthesis.
16 May 2023
Researchers at Kanazawa University report in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) high-speed atomic force microscopy experiments that show how ligands associated with stimulating and suppressing activation of the TRPV1 protein increase and decrease the molecule’s structural variations. The observations provide insights into how these heat- and chilli-sensing proteins function.
15 May 2023
Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy leads to insights into processes relevant to Alzheimer’s disease. Moreover, the technique is shown to be an excellent tool for studying the effect of drugs against the disease.
10 May 2023
A new drug delivery system delivers an antioxidant directly to mitochondria in the liver, mitigating the effects of oxidative stress.
02 Mar 2023
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice, where it was highly effective at knocking down expression of a target protein.
08 Feb 2023
Hokkaido University researchers have developed a novel method to design and develop peptide antibiotics in large numbers, which will prove critical to controlling antibiotic resistance.
02 Feb 2023
Researchers from Osaka University have used single carbon atom doping to form four chemical bonds in one step. Gamma-lactams (cyclic molecules that are common in antibiotics) were easily synthetically accessible from alpha, beta-unsaturated amides (an important molecule in cancer progression). The team chemically modified an anti-seizure medication in 96% yield, highlighting the work's utility to otherwise synthetically complex aspects of pharmaceutical development. The results of this work could become foundational to drug discovery and development.
17 Jan 2023
Researchers led by Osaka University demonstrated the role of endothelial cell-specific protein Roundabout4 (Robo4) in the reduction of vascular permeability and mortality in mouse models of severe infection. The research team identified a drug inhibitor that increased Robo4 expression and reduced mortality in sepsis and SARS-CoV-2 mouse models of infection. These findings may aid in the development of drugs to reduce the mortality rate of severe infectious diseases.
20 Dec 2022
Researchers have designed and synthesized analogs of a new antibiotic that is effective against multidrug-resistant bacteria, opening a new front in the fight against these infections.
10 Nov 2022
A novel branched lipid that has a high stability in storage and a high efficiency in the delivery of mRNA to cells has been developed.
09 Nov 2022
Researchers from Osaka University and Dusseldorf University have found a new theranostic compound that effectively shrinks prostate tumor in mice. Theranostics is a cancer treatment that involves finding cancer cells anywhere in the body and delivering targeted radiation to kill those cells, by drugs that contain radioactive isotopes. It means that this compound could be a promising option for treating hormone-resistant metastases in patients with recurrent cancers. This is stated to be tested in an upcoming clinical trial.
01 Nov 2022
A research group at Osaka Metropolitan University has developed a drug delivery system that activates a strong cellular immune response to attack cancer cells, using one-tenth of the amount of antigen needed in the group’s previous work. By incorporating positively charged cationic lipids into liposomes and adding negatively charged pH-responsive polysaccharides to the surface, the research group increased the uptake efficiency of liposomes encapsulating cancer antigens by dendritic cells by approximately five times, which increased cytokine production by about 100 times. This increased M1-type macrophages, which activate cancer immunity, and decreased M2-type macrophages, which promote cancer growth.
24 Jan 2022
Broccoli may contain advantages beyond nutrition. A molecule found in broccoli, cabbage and more digests down into DIM, a compound with brighter benefits than the name implies, such as inducing cell death in breast, prostate and colon cancer. Now, researchers are beginning to understand the mechanism underpinning this molecular behavior — information that could help elucidate future anti-cancer treatments.
28 Dec 2021
Researchers from Osaka City University have shown in mice models of Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies, that the intranasal administration of rifampicin and resveratrol in combination is safer and improves cognitive function more than rifampicin alone. The research results are expected to lead to the development of safe and effective nasal spray for the prevention of dementia.
17 Sep 2021
A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.
10 Sep 2021
Researchers have identified a potential reason why lower numbers of COVID cases have appeared amongst smokers compared to non-smokers, even as other reports suggest smoking increases severity of the disease.
02 Sep 2021
Researchers at Kanazawa University describe in Scientific Reports the identification of small compounds that can regulate the cellular production of extracellular vesicles — nanocontainers transporting biomolecules between cells. Such compounds hold promise for use in therapies for various diseases.
Events
12 Mar 2025 to 13 Mar 2025
Discover how AI and digitalization are transforming the Global Biopharma Industry. Join industry leaders at the Biologics Digitalization & AI World conference.
09 Dec 2020 to 11 Dec 2020
Singapore's long-running Pharmaceutical Manufacturing Industry learning and networking event, featuring a stellar profile of C-suite experts and firms.
03 Nov 2020 to 05 Nov 2020
Your go-to event to reach out to key decision makers in the pharmaceutical industry. The event will be delivered digitally from 3-5 November 2020.
Researchers
I am an efficient Professor able to Develop courses with IT skills & sound teaching skills in a manner attractive to students. I have vast experience in supervising postgraduate research & Contribute in a well manner to the ongoing academic development of the School’s postgraduate courses and research.
Dr Yap is currently a Senior Lecturer and Program Director of Medical Bioscience at Monash University Malaysia. She is dedicated to toxin pharmacology and toxicology research. She has strong background in biomolecular modelling, proteomics, immunological and molecular pharmacology of bioactive toxins. She leads the Toxin Pharmacology Research Group. Her research group now focuses on molecular mechanisms of cytotoxin with the ultimate goal of developing next-generation biotherapeutics. Her research works have been featured in prominent media outlets, including the International Snakebite Awareness Day campaign. Besides active in research, she is also an education innovator who adopts various active learning strategies with technology. She teaches undergraduate units with an emphasis on student-cantered learning using the andragogy approach. Dr Michelle enjoys promoting STEM education to the public. She has organized and hosted several workshops and forums to advance the disciplines in medical sciences through research and education.
Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She specializes in critical care medicine, infectious diseases and antimicrobial resistance research.
My research background covers multidisciplinary fields such as Pharmaceutics, Cancer Nanomedicine, Bioengineering and Organ-on-a-chip platforms. My current research focuses on the development of dynamic biological barriers on a chip such as blinking human cornea on a chip.
Giants in history
Japanese biochemist Akira Endo (1933 – 2024) discovered the first statin, called mevastatin, which lowered cholesterol levels in the blood by inhibiting a key enzyme in the cholesterol biosynthesis pathway. His work laid the foundation for the development of statins to help patients lower their blood cholesterol levels and reduce their risk of heart disease or stroke.
Tu Youyou (born 30 December 1930) is a Chinese pharmaceutical scientist who was awarded the 2015 Nobel Prize in Physiology or Medicine for her work on extracting artemisin from sweet wormwood to treat malaria.
David T. Wong (born 1936) is a Hong Kong-born American neuroscientist who is best known for discovering the antidepressant drug fluoxetine, better known as Prozac.
Filipino chemist and pharmacist Manuel A. Zamora (29 March 1870 – 9 July 1929) is best remembered for his discovery of the tiki-tiki formula to combat beriberi, a disease caused by Vitamin B1 deficiency.
Filipina chemist María Orosa (29 November 1892–13 February 1945) fought malnutrition and food insecurity in the Philippines by devising over 700 culinary creations including Soyalac, a nutrient rich drink made from soybeans, and Darak, rice cookies packed with Vitamin B1, which could prevent beriberi disease caused by Vitamin B1 deficiency. She was also a partisan of the guerrilla movement resisting Japanese occupation during World War II, and died after being struck by shrapnel while working in her laboratory during the Battle of Manila.
The research of Filipino pharmaceutical chemist Luz Oliveros-Belardo (3 November 1906 – 12 December 1999) focussed on essential oils and other chemicals derived from native Philippine plants.
Japanese chemist Takamine Jokichi (3 November 1854 – 22 July 1922) founded the Tokyo Artificial Fertilizer Company, where he isolated a starch-digesting enzyme (named takadiastase) from the fungus Aspergillus oryzae.